Samsara BioCapital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001744967 · Show all filings

Period: Q4 2018 (Next →)

Filing Date: Feb 14, 2019

Total Value: $104M (100.0% shares, 0.0% debt)

Holdings (17)

— Allakos Inc 23.0%

Value $23.96M Shares 458,366 Est. Cost $52.27 Unrealized —

— Intercept Pharmaceuticals Inc 22.7%

Value $23.62M Shares 234,375 Est. Cost $100.79 Unrealized —

— Principia Biopharma Inc 10.1%

Value $10.5M Shares 383,480 Est. Cost $27.39 Unrealized —

— Sutro BioPharma Inc 9.7%

Value $10.15M Shares 1,125,576 Est. Cost $9.02 Unrealized —

— Odonate Therapeutics Inc 8.1%

Value $8.39M Shares 595,850 Est. Cost $14.08 Unrealized —

LQDA Liquidia Technologies Inc 7.9%

Value $8.197M Shares 378,420 Est. Cost $23.38 Unrealized 0.0%

— Syros Pharmaceuticals Inc 5.7%

Value $5.904M Shares 1,059,938 Est. Cost $5.57 Unrealized —

KALV KalVista Pharmaceuticals Inc 2.8%

Value $2.963M Shares 150,000 Est. Cost $20.10 Unrealized 0.0%

— Evelo Biosciences Inc 2.8%

Value $2.96M Shares 227,529 Est. Cost $13.01 Unrealized —

— Miragen Therapeutics Inc 2.6%

Value $2.755M Shares 909,090 Est. Cost $3.03 Unrealized —

— Aravive Inc 1.5%

Value $1.558M Shares 442,733 Est. Cost $3.52 Unrealized —

— Catabasis Pharmaceuticals Inc 1.3%

Value $1.311M Shares 300,000 Est. Cost $4.37 Unrealized —

UROV Urovant Sciences Ltd 1.0%

Value $1.038M Shares 157,480 Est. Cost $6.59 Unrealized —

— Millendo Therapeutics Inc 0.3%

Value $359K Shares 45,101 Est. Cost $7.96 Unrealized —

— Surface Oncology Inc 0.3%

Value $332K Shares 78,300 Est. Cost $4.24 Unrealized —

— Trillium Therapeutics Inc 0.1%

Value $122K Shares 71,619 Est. Cost $1.70 Unrealized —

— Edge Therapeutics Inc 0.1%

Value $59,000 Shares 183,332 Est. Cost $0.32 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Allakos Inc	458,366	$23.96M	23.0%	$52.27	—	COM	01671P100
—	Intercept Pharmaceuticals Inc	234,375	$23.62M	22.7%	$100.79	—	COM	45845P108
—	Principia Biopharma Inc	383,480	$10.5M	10.1%	$27.39	—	COM	74257L108
—	Sutro BioPharma Inc	1,125,576	$10.15M	9.7%	$9.02	—	COM	869367102
—	Odonate Therapeutics Inc	595,850	$8.39M	8.1%	$14.08	—	COM	676079106
LQDA	Liquidia Technologies Inc	378,420	$8.197M	7.9%	$23.38	0.0%	COM	53635D202
—	Syros Pharmaceuticals Inc	1,059,938	$5.904M	5.7%	$5.57	—	COM	87184Q107
KALV	KalVista Pharmaceuticals Inc	150,000	$2.963M	2.8%	$20.10	0.0%	COM	483497103
—	Evelo Biosciences Inc	227,529	$2.96M	2.8%	$13.01	—	COM	299734103
—	Miragen Therapeutics Inc	909,090	$2.755M	2.6%	$3.03	—	COM	60463E103
—	Aravive Inc	442,733	$1.558M	1.5%	$3.52	—	COM	03890D108
—	Catabasis Pharmaceuticals Inc	300,000	$1.311M	1.3%	$4.37	—	COM	14875P206
UROV	Urovant Sciences Ltd	157,480	$1.038M	1.0%	$6.59	—	COM	G9381B108
—	Millendo Therapeutics Inc	45,101	$359K	0.3%	$7.96	—	COM	60040X103
—	Surface Oncology Inc	78,300	$332K	0.3%	$4.24	—	COM	86877M209
—	Trillium Therapeutics Inc	71,619	$122K	0.1%	$1.70	—	COM	89620X506
—	Edge Therapeutics Inc	183,332	$59,000	0.1%	$0.32	—	COM	279870109